Improved product purity

Easy and effective dsRNA clearance

High target molecule yield

High specificity afforded by novel affinity ligand with low non-specific binding

Novel scavenging affinity resin

Scalable solution that does not require solvents or heating

Improve mRNA product purity

Superior mRNA therapeutics with precise dsRNA removal

Efficient removal of dsRNA is essential to ensure the safety and efficacy of mRNA biotherapeutics. AVIPure dsRNA Clear affinity resin prepacked in OPUS columns has emerged as a highly effective solution for this challenge, offering precise and reliable separation of dsRNA from single-stranded RNA (ssRNA). By leveraging specific binding interactions, affinity chromatography enhances the purity and quality of RNA-based therapeutics, ultimately contributing to their success in clinical applications.

AVIPure dsRNA Clear is the first and only bead based, affinity chromatography solution for removing dsRNA impurities from mRNA preparations. The solution is targeted, eliminates the use of organic solvents (EtOH), negates the need for a non-specific and non-scalable removal methods and sets the standard for dsRNA impurity clearance in mRNA production processes.

Chromatogram showing dsRNA depleted flow through

Chromatogram showing dsRNA depleted flow through.

The absorbance trace on a chromatogram will show a broad peak during the loading as the mRNA is flowing through.

Experimental conditions

  • Column: 0.2 mL AVIPure dsRNA Clear OPUS column
  • Buffer: 10 mM Tris pH 8, 0.5 M NaCl, 0.5 mM EDTA
  • Elution/CIP: 6 M guanidine HCl
  • Flow rate: 0.4 mL/min (30 sec RT)
  • Feed: 0.51 mg/mL fLuc with 1.4% dsRNA (by ELISA)
  • Challenge: 10.2 mg fLuc/mLCV
  • Sample application method: Dynamic loop
  • Sample volume: 20 CVs
Product performance

Optimized dsRNA clearance for therapeutic success

To help scientists to accelerate therapeutic development, AVIPure dsRNA Clear OPUS columns are designed to remove double stranded RNA from complex feedstocks via affinity chromatography. The resin enables users to maintain high target molecule recovery while eliminating dsRNA from the feedstock. Easily scale from process development to clinical and commercial manufacturing using this resin, which is available exclusively in OPUS pre-packed chromatography columns.

The highest clearance of dsRNA, typically two to three log reduction, is observed with optimized IVT feeds with already low dsRNA levels where RNA presents as a single, sharp band on a gel. Even in unoptimized feeds with higher dsRNA content, or where RNA appears as a smear or ladder on a gel, users are able to achieve a few fold reduction of dsRNA.

Performance and Efficiency

  • High Dynamic Binding Capacity: ≥0.4 mg dsRNA/mLcolumn volume at 10% breakthrough
  • Selectivity: Resin selectively binds double stranded RNA in high salt (>0.5 M NaCl) from pH 7.2-9.5 for easily impurity removal. mRNA, circular RNA, and self-amplifying RNA flows through.
  • Purity and Yield: Superior product purity and yield, delivering excellent target molecule recovery with limited product loss

Operational Benefits

  • Ease of Use: Resin operates in flow through mode with aqueous buffers. No elution required.
  • Reduced Processing Time: High volumetric throughput with optimal clearance achieved with 1-minute residence time.
  • No solvents required: Only aqueous buffers are required, no solvents or heating are needed to operate this resin.

Regulatory Compliance and Safety

  • Compliance with Industry Standards: Large scale columns are ready for use in GMP processing.
  • Biocompatibility and Safety: AVIPure dsRNA Clear OPUS columns are free from animal derived components. Residual ligand ELISA kit available for detection of leached ligand.

Support and Service

  • Technical Support: Expert technical support is available for product implementation and process optimization.
Request Access

Techniques for measuring and removing dsRNA byproducts from in vitro transcribed RNA

Double-stranded RNA byproducts can trigger unwanted immune responses, representing a significant concern for RNA therapeutics. Measuring dsRNA contaminants and subsequently removing them are key to ensuring the safety and efficacy of mRNA, circRNA, and saRNA therapeutics.

Artist's rendering of double stranded RNA

A scalable purification strategy for removal of dsRNA byproduct

This article describes the development, validation, and application of the AVIPure dsRNA Clear affinity resin to remove immunogenic dsRNA impurities in mRNA therapeutics.


An immuno-northern technique to measure the size of dsRNA byproducts in IVT RNA

This article describes a method for determining the sizes of dsRNA byproducts in mRNA feed streams, developed by Repligen scientists.

Complete this form to request access to the articles.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Maximize Efficiency with AVIPure dsRNA Clear in OPUS Columns

Achieve precise double-stranded RNA removal from complex feedstocks with AVIPure dsRNA Clear. Ready to take the next step?

  • Speak with a technical specialist: Complete the form to discuss your needs and get expert guidance.
  • Order now: Visit our e-store to evaluate AVIPure dsRNA Clear today.
Volume Part Number Format dsRNA Capacity Approx. mRNA to load
5 mL 100RNA-5 5 mL loose resin in 18-20% EtOH; ideal for high throughput screening in 96-well plates or drip columns. 0.4 mg dsRNA per mL resin 10 mg per mL of resin
0.5 mL 23052205 0.5 x 2.5 cm Minichrom® column 0.2 mg 5 mg
1 mL 23052206 0.5 x 5 cm MiniChrom® column 0.4 mg 10 mg
5 mL 23052204-100 0.8 x 10 cm MiniChrom® column 2 mg 50 mg

To learn more about our solutions for mRNA manufacturing, please click here.